Zélie Julia

2.0k total citations
12 papers, 523 citations indexed

About

Zélie Julia is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Zélie Julia has authored 12 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 6 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Oncology. Recurrent topics in Zélie Julia's work include Cholesterol and Lipid Metabolism (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Zélie Julia is often cited by papers focused on Cholesterol and Lipid Metabolism (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Zélie Julia collaborates with scholars based in France, United States and Canada. Zélie Julia's co-authors include Maryse Guérin, Wilfried Le Goff, M. John Chapman, Emilie Duchêne, Natalie Fournier, M. John Chapman, Éric Bruckert, Éric Frisdal, Alain Carrié and Judith Fresquet and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Arteriosclerosis Thrombosis and Vascular Biology and Journal of Lipid Research.

In The Last Decade

Zélie Julia

12 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zélie Julia France	11	319	193	110	93	78	12	523
Kazuhide Takata Japan	10	239 0.7×	158 0.8×	178 1.6×	75 0.8×	139 1.8×	54	577
Antonina Giammanco Italy	13	154 0.5×	113 0.6×	106 1.0×	92 1.0×	28 0.4×	50	482
Chunhua Lin China	11	119 0.4×	87 0.5×	191 1.7×	44 0.5×	58 0.7×	33	491
R Bonardi Italy	11	232 0.7×	54 0.3×	169 1.5×	31 0.3×	132 1.7×	23	464
Julia Perttilä Finland	15	191 0.6×	319 1.7×	410 3.7×	110 1.2×	104 1.3×	17	873
Soichiro Saikawa Japan	13	130 0.4×	127 0.7×	245 2.2×	76 0.8×	185 2.4×	26	593
Jie‐Jun Hu China	11	99 0.3×	128 0.7×	159 1.4×	71 0.8×	58 0.7×	23	466
Babak Movahedi United States	14	496 1.6×	239 1.2×	44 0.4×	23 0.2×	89 1.1×	30	634
Rasha Elzehery Egypt	13	152 0.5×	79 0.4×	272 2.5×	29 0.3×	169 2.2×	43	493
Hermien Hartog Netherlands	14	239 0.7×	154 0.8×	95 0.9×	81 0.9×	151 1.9×	50	676

Countries citing papers authored by Zélie Julia

Since Specialization

Citations

This map shows the geographic impact of Zélie Julia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zélie Julia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zélie Julia more than expected).

Fields of papers citing papers by Zélie Julia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zélie Julia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zélie Julia. The network helps show where Zélie Julia may publish in the future.

Co-authorship network of co-authors of Zélie Julia

This figure shows the co-authorship network connecting the top 25 collaborators of Zélie Julia. A scholar is included among the top collaborators of Zélie Julia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zélie Julia. Zélie Julia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Isernia, Valentina, Zélie Julia, Sylvie Le Gac, et al.. (2020). SARS-COV2 infection in 30 HIV-infected patients followed-up in a French University Hospital. International Journal of Infectious Diseases. 101. 49–51. 14 indexed citations

Sénard, Olivia, Charles Burdet, Benoît Visseaux, et al.. (2016). Epidemiological Profile of Newly Diagnosed HIV-Infected Patients in Northern Paris: A Retrospective Study. AIDS Research and Human Retroviruses. 33(1). 11–16. 4 indexed citations

Abifadel, Marianne, Maryse Guérin, Suzanne Benjannet, et al.. (2012). Identification and characterization of new gain-of-function mutations in the PCSK9 gene responsible for autosomal dominant hypercholesterolemia. Atherosclerosis. 223(2). 394–400. 87 indexed citations

Julia, Zélie, Elise F. Villard, Petra El Khoury, et al.. (2012). Functionality of postprandial larger HDL2 particles is enhanced following CETP inhibition therapy. Atherosclerosis. 221(1). 160–168. 25 indexed citations

Plengpanich, Wanee, et al.. (2011). CETP deficiency due to a novel mutation in the CETP gene promoter and its effect on cholesterol efflux and selective uptake into hepatocytes. Atherosclerosis. 216(2). 370–373. 21 indexed citations

Aron‐Wisnewsky, Judith, Zélie Julia, Christine Poitou, et al.. (2011). Effect of Bariatric Surgery-Induced Weight Loss on SR-BI-, ABCG1-, and ABCA1-Mediated Cellular Cholesterol Efflux in Obese Women. The Journal of Clinical Endocrinology & Metabolism. 96(4). 1151–1159. 66 indexed citations

Orsoni, Alexina, Zélie Julia, Natalie Fournier, et al.. (2011). Atheroprotective Reverse Cholesterol Transport Pathway Is Defective in Familial Hypercholesterolemia. Arteriosclerosis Thrombosis and Vascular Biology. 31(7). 1675–1681. 66 indexed citations

Julia, Zélie, Emilie Duchêne, Natalie Fournier, et al.. (2010). Postprandial lipemia enhances the capacity of large HDL2 particles to mediate free cholesterol efflux via SR-BI and ABCG1 pathways in type IIB hyperlipidemia. Journal of Lipid Research. 51(11). 3350–3358. 17 indexed citations

Dreux, Marlène, Viet Loan Dao Thi, Judith Fresquet, et al.. (2009). Receptor Complementation and Mutagenesis Reveal SR-BI as an Essential HCV Entry Factor and Functionally Imply Its Intra- and Extra-Cellular Domains. PLoS Pathogens. 5(2). e1000310–e1000310. 100 indexed citations

10.

Julia, Zélie, Éric Frisdal, Benoı̂t Vedie, et al.. (2008). Torcetrapib Differentially Modulates the Biological Activities of HDL2 and HDL3 Particles in the Reverse Cholesterol Transport Pathway. Arteriosclerosis Thrombosis and Vascular Biology. 29(2). 268–275. 51 indexed citations

11.

Duchêne, Emilie, Zélie Julia, Wilfried Le Goff, et al.. (2007). Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjects. Journal of Lipid Research. 49(3). 635–643. 45 indexed citations

12.

Guérin, Maryse, Wilfried Le Goff, Emilie Duchêne, et al.. (2007). Inhibition of CETP by Torcetrapib Attenuates the Atherogenicity of Postprandial TG-Rich Lipoproteins in Type IIB Hyperlipidemia. Arteriosclerosis Thrombosis and Vascular Biology. 28(1). 148–154. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact